Nothing Special   »   [go: up one dir, main page]

AP2009004891A0 - New azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents

New azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them

Info

Publication number
AP2009004891A0
AP2009004891A0 AP2009004891A AP2009004891A AP2009004891A0 AP 2009004891 A0 AP2009004891 A0 AP 2009004891A0 AP 2009004891 A AP2009004891 A AP 2009004891A AP 2009004891 A AP2009004891 A AP 2009004891A AP 2009004891 A0 AP2009004891 A0 AP 2009004891A0
Authority
AP
ARIPO
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
azabicyclic compounds
new
Prior art date
Application number
AP2009004891A
Other languages
English (en)
Inventor
Anita Roger
Anne-Marie Chollet
Alain Dhainaut
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AP2009004891A0 publication Critical patent/AP2009004891A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AP2009004891A 2008-06-13 2009-06-08 New azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them AP2009004891A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0803297A FR2932479A1 (fr) 2008-06-13 2008-06-13 Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
AP2009004891A0 true AP2009004891A0 (en) 2009-06-30

Family

ID=40227963

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2009004891A AP2009004891A0 (en) 2008-06-13 2009-06-08 New azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them

Country Status (29)

Country Link
US (1) US7906547B2 (pt)
EP (1) EP2133333A1 (pt)
JP (1) JP2009298790A (pt)
KR (1) KR20090129958A (pt)
CN (1) CN101602706A (pt)
AP (1) AP2009004891A0 (pt)
AR (1) AR072101A1 (pt)
AU (1) AU2009202341A1 (pt)
BR (1) BRPI0902395A2 (pt)
CA (1) CA2668527A1 (pt)
CL (1) CL2009001377A1 (pt)
CO (1) CO6190096A1 (pt)
CR (1) CR10844A (pt)
EA (1) EA200900692A1 (pt)
EC (1) ECSP099396A (pt)
FR (1) FR2932479A1 (pt)
GT (1) GT200900150A (pt)
MA (1) MA31141B1 (pt)
MX (1) MX2009005891A (pt)
MY (1) MY144748A (pt)
NI (1) NI200900114A (pt)
NZ (1) NZ577438A (pt)
PE (1) PE20091961A1 (pt)
SG (1) SG158015A1 (pt)
SV (1) SV2009003292A (pt)
TW (1) TW201000101A (pt)
UY (1) UY31857A1 (pt)
WO (1) WO2009150331A1 (pt)
ZA (1) ZA200903939B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10892398B2 (en) * 2019-03-28 2021-01-12 Johannes Pollanen Qubit hardware for electrons on helium
WO2022113008A1 (en) 2020-11-27 2022-06-02 Richter Gedeon Nyrt. Histamine h3 receptor antagonists/inverse agonists for the treatment of autism spectrum disorder

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515013B2 (en) * 2000-07-13 2003-02-04 Abbott Laboratories 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
ATE400553T1 (de) * 2002-12-10 2008-07-15 Ranbaxy Lab Ltd 3,6-disubstituierte azabicyclo 3.1.0 - hexanderivative als antagonisten des muscarinrezeptors
FR2866647B1 (fr) * 2004-02-20 2006-10-27 Servier Lab Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1707203A1 (en) * 2005-04-01 2006-10-04 Bioprojet Treatment of parkinson's disease obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine H3- receptor ligands
UA88518C2 (ru) * 2005-04-08 2009-10-26 Пфайзер Продактс Инк. Бицикло[3,1,0]гетероариламиды как ингибиторы транспорта глицина типа i
EP1842846A1 (en) * 2006-04-07 2007-10-10 Santhera Pharmaceuticals (Schweiz) AG Phenylpiperidine derivatives as melanocortin-4 receptor modulators
GB2454615A (en) * 2006-07-21 2009-05-13 Lupin Ltd Antidiabetic azabicyclo (3.1.0) hexan compounds

Also Published As

Publication number Publication date
MX2009005891A (es) 2010-02-17
CR10844A (es) 2009-07-23
UY31857A1 (es) 2009-08-31
BRPI0902395A2 (pt) 2010-04-20
AR072101A1 (es) 2010-08-04
SG158015A1 (en) 2010-01-29
NI200900114A (es) 2010-02-03
GT200900150A (es) 2011-08-25
EP2133333A1 (fr) 2009-12-16
CL2009001377A1 (es) 2010-05-28
TW201000101A (en) 2010-01-01
AU2009202341A1 (en) 2010-01-07
EA200900692A1 (ru) 2009-12-30
ZA200903939B (en) 2010-04-28
MY144748A (en) 2011-10-31
US20090312389A1 (en) 2009-12-17
PE20091961A1 (es) 2010-01-23
ECSP099396A (es) 2010-01-29
SV2009003292A (es) 2010-02-01
NZ577438A (en) 2010-09-30
WO2009150331A1 (fr) 2009-12-17
US7906547B2 (en) 2011-03-15
MA31141B1 (fr) 2010-02-01
CO6190096A1 (es) 2010-08-19
KR20090129958A (ko) 2009-12-17
FR2932479A1 (fr) 2009-12-18
JP2009298790A (ja) 2009-12-24
CN101602706A (zh) 2009-12-16
CA2668527A1 (fr) 2009-12-13

Similar Documents

Publication Publication Date Title
ZA200704957B (en) Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
IL215016A0 (en) New benzothiadiazepine compounds, a process for their preparation and pharmaceutical compositions containing them
AP2014007774A0 (en) New pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them
AP3024A (en) New Diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them
SG151172A1 (en) 1,2,4,5-tetrahydro-3h-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them
IL200128A0 (en) New tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them
HK1155742A1 (en) Dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
IL218525A (en) Compounds 2,1 - Dihydro - 2 - Oxoquinoline Receptor Legendants 5 - 4ht Process for Preparing, Containing and Using Medical Preparations
HK1111403A1 (en) New naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
ZA201000025B (en) New naphthalene compounds,a process for their preparation and pharmaceutical compositions containing them
AP2009004891A0 (en) New azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them
IL206885A0 (en) New chromene compounds, a process for their preparation and pharmaceutical compositions containing them
ZA201000024B (en) New naphthalene compounds,a process for their preparation and pharmaceutical compositions containing them
ZA201106353B (en) Dihydrobenzoxathiazepine compounds,a process for their preparation and pharmaceutical compositions containing them
AP2010005304A0 (en) New 2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them
HK1176355A1 (en) Dihydro oxazolobenzodiazepinone compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200704956B (en) Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
ZA201203943B (en) New azabicyclo[3.1.0]hex-2-yl compounds,a process for their preparation and pharmaceutical compositions containing them
IL206884A0 (en) New piperidine compounds, a process for their preparation and pharmaceutical compositions containing them
AP2755A (en) New azabicyclo[3.2.0]hept-3-yl compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200708215B (en) Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them
AP2010005327A0 (en) New chromene compounds, a process for their preparation and pharmaceutical compositions containing them.
HU0900381D0 (en) Nanoparticulate ezetimibe compositions, process for the preparation thereof and pharmaceutical compositions containing them